Top Markets
#1 Trillions Trillions +4,371.27%
#2 Ozapay Ozapay +38.46%
#3 UnifAI Network UnifAI Network +23.35%
#4 Aria.AI Aria.AI +22.13%
#5 Zano Zano +17.76%
#6 Osaka Protocol Osaka Protocol +14.37%
#7 StakeStone StakeStone +14.34%
#8 Vestra DAO Vestra DAO +12.12%
#9 River Pts River Pts +10.84%
#10 Janction Janction +10.23%
Coin of the day
Trillions Trillions
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rang in Aktien #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Aktienkurs
$0.28545656
Marktkapitalisierung
$4.50M
Veränderung (1 Tag)
5.97%
Veränderung (1 Jahr)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategorie

Healthcare
Dividendenhistorie für Acticor Biotech SAS (ALACT)
Acticor Biotech SAS (Aktienkürzel: ALACT) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Acticor Biotech SAS (ALACT) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
52.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.00%
US
UCB SA UCB SA
UCB SA
UCB.BR
29.00%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU